could be but would only happen on a big positive COAST result to pay for more market preparations. wouldnt be a problem IMO. The longer they keep the drug in house and get ready for market the more money they can make in the end, by takeover from Pfizer or others, licensing multiple players nonexclusively or going to market themselves.
Ann: Opthea Completes Placement & Institutional Entitlement Offer, page-10
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
34.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $376.5M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 34.0¢ | $402.5K | 1.164M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 19 | 506452 | 34.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 1059809 | 5 |
View Market Depth
| Last trade - 16.10pm 25/06/2024 (20 minute delay) ? |
| OPT (ASX) Chart |